Eigen Bio is a biotechnology company harnessing advanced AI to decode the human transcriptome and unlock new frontiers in precision health. From aging to chronic disease, we develop powerful tools and models that analyze RNA in real-time—empowering individuals and institutions to understand, predict, and act on biological change.
We believe RNA is the most dynamic signal of health. Our mission is to make it accessible, actionable, and personal.
Sentinel powered by Eigen Bio
Your RNA, Your Digital Twin, Your Health—Monitored in Real Time
Sentinel is Eigen Bio’s first direct-to-consumer product: an RNA-based health monitoring platform that turns a simple at-home test into a living map of your molecular health. With AI-driven insights and continuous tracking, Sentinel detects signals of aging, inflammation, and early disease—before symptoms appear.
Because prevention starts at the molecular level.
Company Details
- Employees
- 2
- Address
- New York City, Ny 11101, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://sentinel.eigenbioai.com
- Keywords
- biotechnology, AI, deep learning, RNA.
- HQ
- New York City, NY
Eigen Bio Questions
Eigen Bio's website is https://sentinel.eigenbioai.com
Eigen Bio's LinkedIn profile is https://www.linkedin.com/company/eigen-bio-ai
Eigen Bio has
2 employees.
View email and phone details for 2
employees at Eigen Bio.
Eigen Bio's industry is
Biotechnology Research
Eigen Bio's top competitors are
Robothink,
Crypto United Partners Ltd.,
Konstellation Labs,
Starry Eyed Tomorrow,
Vegax Technologies,
Parataxis Capital,
Ontos,
Tck Investments,
Thirdlab Studio,
Collie Ai.
Eigen Bio's categories are Biotechnology Research
